Abstract
This review summarizes recent data on the use of HSV-1 – based amplicon vectors for in vivo gene delivery to the brains of rats and mice to study and modify behaviour. Here we describe studies that have focused on cognitive functions like learning and memory. In addition, the use of amplicons in other behavioural studies, like addiction, social interaction, anxiety and stress, will be briefly updated. Several remarkable findings have been achieved, thanks to the use of these very efficient and non-toxic naturally neurotropic vectors, most particularly the consistent observation that genetic manipulation of a rather limited number of neurons in restricted regions of the brain, could result in significant behavioural changes, a notion that is therefore emerging as a common unifying hypothesis, thanks to these works.
Keywords: HSV-1 vectors, Addiction, ventral tegmental area (VTA), cAMP response element-binding protein (CREB), NMDAR-mediated synaptic plasticity, memory
Current Gene Therapy
Title: Amplicon Vectors as Outstanding Tools to Study and Modify Cognitive Functions
Volume: 6 Issue: 3
Author(s): Diana Jerusalinsky and Alberto L. Epstein
Affiliation:
Keywords: HSV-1 vectors, Addiction, ventral tegmental area (VTA), cAMP response element-binding protein (CREB), NMDAR-mediated synaptic plasticity, memory
Abstract: This review summarizes recent data on the use of HSV-1 – based amplicon vectors for in vivo gene delivery to the brains of rats and mice to study and modify behaviour. Here we describe studies that have focused on cognitive functions like learning and memory. In addition, the use of amplicons in other behavioural studies, like addiction, social interaction, anxiety and stress, will be briefly updated. Several remarkable findings have been achieved, thanks to the use of these very efficient and non-toxic naturally neurotropic vectors, most particularly the consistent observation that genetic manipulation of a rather limited number of neurons in restricted regions of the brain, could result in significant behavioural changes, a notion that is therefore emerging as a common unifying hypothesis, thanks to these works.
Export Options
About this article
Cite this article as:
Jerusalinsky Diana and Epstein L. Alberto, Amplicon Vectors as Outstanding Tools to Study and Modify Cognitive Functions, Current Gene Therapy 2006; 6 (3) . https://dx.doi.org/10.2174/156652306777592027
DOI https://dx.doi.org/10.2174/156652306777592027 |
Print ISSN 1566-5232 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5631 |
Call for Papers in Thematic Issues
Programmed Cell Death Genes in Oncology: Pioneering Therapeutic and Diagnostic Frontiers (BMS-CGT-2024-HT-45)
Programmed Cell Death (PCD) is recognized as a pivotal biological mechanism with far-reaching effects in the realm of cancer therapy. This complex process encompasses a variety of cell death modalities, including apoptosis, autophagic cell death, pyroptosis, and ferroptosis, each of which contributes to the intricate landscape of cancer development and ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Joint Effect of ABCA7 rs4147929 and Body Mass Index on Progression from Mild Cognitive Impairment to Alzheimer’s Disease: The Shanghai Aging Study
Current Alzheimer Research Associations of Plasma BACE1 Level and BACE1 C786G Gene Polymorphism with Cognitive Functions in Patients with Type 2 Diabetes: A Cross- Sectional Study
Current Alzheimer Research Ototoxicity: Mechanisms of Cochlear Impairment and its Prevention
Current Medicinal Chemistry Senescence of the Brain: Focus on Cognitive Kinases
Current Pharmaceutical Design Alport Syndrome: A Comprehensive Review on Genetics, Pathophysiology, Histology, Clinical and Therapeutic Perspectives
Current Medicinal Chemistry Editorial:Cannabis: Neurological Correlates in Abuse and Medical Use
CNS & Neurological Disorders - Drug Targets Association between Delirium and Cognitive Impairment: Is there a Link?
Current Alzheimer Research Important Hints in Behavioural Teratology of Rodents
Current Pharmaceutical Design Conditioned Avoidance Response in the Development of New Antipsychotics
Current Pharmaceutical Design Pro-Inflammatory Gene Variants in Myocardial Infarction and Longevity: Implications for Pharmacogenomics
Current Pharmaceutical Design Functional Neurochemistry of Alzheimers Disease
Current Pharmaceutical Design Cholinergic Treatment of Traumatic Brain Injury
Current Drug Therapy In vivo Fluorescence Detection in Surgery: A Review of Principles, Methods, and Clinical Applications
Current Medical Imaging Maternal Choline Supplementation: A Potential Prenatal Treatment for Down Syndrome and Alzheimer’s Disease
Current Alzheimer Research Neurodynamic Activation Interface for Improving a Subjects Sensory, Reflex and/or Motor Mechanisms via Auditory, Tactile or Visual Stimulations
Recent Patents on Electrical Engineering REM sleep and its Loss-Associated Epigenetic Regulation with Reference to Noradrenaline in Particular
Current Neuropharmacology Extracellular Signal-Regulated Kinases Modulate DNA Damage Response - A Contributing Factor to Using MEK Inhibitors in Cancer Therapy
Current Medicinal Chemistry Vasopressin in Health and Disease with a Focus on Affective Disorders
Central Nervous System Agents in Medicinal Chemistry The Multifunctional Mesencephalic Locomotor Region
Current Pharmaceutical Design The Effect of Cannabis on Perception of Time: A Critical Review
Current Pharmaceutical Design